Adverts

Open Access Articles- Top Results for Dalotuzumab

Dalotuzumab

</th></tr>
Dalotuzumab?
Monoclonal antibody
Type Whole antibody
Source Humanized (from mouse)
Target IGF-1 receptor
Clinical data
Identifiers
1005389-60-5 7pxN
None
UNII 6YI1L648RH 7pxY
Chemical data
Formula C6528H10086N1730O2018S40
146.4 kDa
 14pxN (what is this?)  (verify)

Dalotuzumab is a humanized monoclonal antibody designed for the treatment of cancers.[1]

Dalotuzumab was developed by Merck & Co., Inc.

References

  1. ^ "Statement On A Nonproprietary Name Adopted By The USAN Council: Dalotuzumab" (PDF). American Medical Association. 


Lua error in package.lua at line 80: module 'Module:Buffer' not found. Lua error in package.lua at line 80: module 'Module:Buffer' not found.